BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11943945)

  • 1. Of liver, whisky and plants: a requiem for colchicine in alcoholic cirrhosis?
    Lonardo A; Loria P
    Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):355-8. PubMed ID: 11943945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis.
    Rambaldi A; Gluud C
    Liver; 2001 Apr; 21(2):129-36. PubMed ID: 11318982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2001; (3):CD002148. PubMed ID: 11687017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colchicine in toxic liver cirrhosis and primary biliary cirrhosis].
    Theilmann L
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():40-2. PubMed ID: 1449015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival.
    Morgan TR; Weiss DG; Nemchausky B; Schiff ER; Anand B; Simon F; Kidao J; Cecil B; Mendenhall CL; Nelson D; Lieber C; Pedrosa M; Jeffers L; Bloor J; Lumeng L; Marsano L; McClain C; Mishra G; Myers B; Leo M; Ponomarenko Y; Taylor D; Chedid A; French S; Kanel G; Murray N; Pinto P; Fong TL; Sather MR
    Gastroenterology; 2005 Apr; 128(4):882-90. PubMed ID: 15825072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial.
    Cortez-Pinto H; Alexandrino P; Camilo ME; Gouveia-Oliveira A; Santos PM; Alves MM; Moura MC
    Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):377-81. PubMed ID: 11943949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Rambaldi A; Gluud C
    Liver; 2000 Jun; 20(3):262-6. PubMed ID: 10902979
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of colchicine in the treatment of alcoholic liver fibrosis in the elderly. Report of 80 cases].
    Mancinella A
    Clin Ter; 1995 Mar; 146(3):191-201. PubMed ID: 7789081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments.
    Lieber CS
    Curr Gastroenterol Rep; 2004 Feb; 6(1):60-5. PubMed ID: 14720455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and treatment of liver fibrosis in alcoholics: 1996 update.
    Lieber CS
    Dig Dis; 1997; 15(1-2):42-66. PubMed ID: 9101129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alcoholic liver diseases and their treatment].
    Cacciatore L; Antoniello S; Russo M
    Clin Ter; 1989 Nov; 131(4):225-32. PubMed ID: 2480864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-TGF-beta strategies for the treatment of chronic liver disease.
    Breitkopf K; Haas S; Wiercinska E; Singer MV; Dooley S
    Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):121S-131S. PubMed ID: 16344596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative mechanisms in the pathogenesis of alcoholic liver disease.
    Albano E
    Mol Aspects Med; 2008; 29(1-2):9-16. PubMed ID: 18045675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine treatment effects on liver cirrhosis assessed by liver blood flow measurements.
    Tăpălagă D; Dumitraşcu D; Cotul S; Stanciu L; Tamaş S
    Med Interne; 1986; 24(1):69-73. PubMed ID: 3704505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic liver disease: new insights in pathogenesis lead to new treatments.
    Lieber CS
    J Hepatol; 2000; 32(1 Suppl):113-28. PubMed ID: 10728799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
    Lieber CS
    Alcohol; 2004 Aug; 34(1):9-19. PubMed ID: 15670660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine in the treatment of cirrhosis of the liver.
    Kershenobich D; Vargas F; Garcia-Tsao G; Perez Tamayo R; Gent M; Rojkind M
    N Engl J Med; 1988 Jun; 318(26):1709-13. PubMed ID: 3287167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D; Coates PM
    Alcohol; 2004 Aug; 34(1):3-8. PubMed ID: 15670659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of colchicine in liver cirrhosis].
    Vilela MP; Chehter L; Parise ER
    Rev Paul Med; 1986; 104(5):271-3. PubMed ID: 3296109
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.
    Reeves HL; Burt AD; Wood S; Day CP
    J Hepatol; 1996 Nov; 25(5):677-83. PubMed ID: 8938545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.